Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News N2OFF enters cancer-drug discovery market through MitoCareX merger Find out how N2OFF’s merger with MitoCareX is reshaping its business and targeting pancreatic & lung cancers! bySoujanya RaviOctober 30, 2025